Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Remotely Targeted and Triggered Drug Delivery Systems

April 24, 2019 (Noon–1 p.m. ET)

Sponsor/Co-Sponsor(s)

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD

Location

Webinar

Purpose

Remotely targeted and triggered drug delivery systems have become areas of considerable interest. This webinar will review the rationales for such systems and their characteristics, when used for local or systemic drug delivery. Presenter Daniel Kohane, M.D., Ph.D., will provide examples of applications in cancer, pain, and diabetes, using a variety of external energy sources as triggers. He also will provide comparisons to non-triggered and non-nanoscale systems as well as discuss the much-debated issue of the depth in tissue at which drug delivery systems can be triggered.

Additionally, Dr. Kohane will help participants understand the rationales behind targeted and triggered drug delivery systems, the types of clinical problems to which they can be adapted, and the types of drug delivery systems and remote triggers they can employ.

Dr. Kohane is a professor of anesthesia at Harvard Medical School and a senior associate in pediatric critical care at Boston Children’s Hospital, where he directs the Laboratory for Biomaterials and Drug Delivery.

Contact

George Giacoia, OPPTB, NICHD
Phone: 301–496–5589
Email: giacoiag@mail.nih.gov

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.